Ziopharm Oncology Announces Over 50% Reduction In Workforce

T-Reuters
28 Sep 2021

ZIOPHARM Oncology Inc :Ziopharm Oncology Announces Strategic Reduction In Workforce And Extension In Cash Runway.Ziopharm Oncology Inc - Cost Reductions Expected To Extend Cash Runway Into First Half Of 2023.Ziopharm Oncology Inc - Over 50% Reduction In Personnel.Ziopharm Oncology Inc - First Patient In Its Tcr-T Library Phase I/Ii Clinical Trial Is Expected To Be Dosed In 1H2022.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10